Skip to main content
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
8.71
+0.92 (11.81%)
At close: Jun 26, 2026, 4:00 PM EDT
8.48
-0.23 (-2.64%)
After-hours: Jun 26, 2026, 7:59 PM EDT

ImmunityBio Employees

As of December 31, 2025, ImmunityBio had 691 total employees, including 684 full-time and 7 part-time employees. The number of employees increased by 11 or 1.62% compared to the previous year.

Employees
691
Change (1Y)
11
Growth (1Y)
1.62%
Revenue / Employee
$204,019
Profits / Employee
-$1,236,663
Market Cap
9.12B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 2025691111.62%
Dec 31, 2024680528.28%
Dec 31, 2023628-97-13.38%
Dec 31, 202272513823.51%
Dec 31, 202158713830.73%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Related Stocks

Company Name Employees
Corcept Therapeutics 730
Vaxcyte 507
Halozyme Therapeutics 423
TG Therapeutics 399
Immunovant 315
Apogee Therapeutics 261
Kymera Therapeutics 253
Nuvalent 234
Employee Rankings

IBRX News

More News